Lantern Pharma(LTRN) - 2025 Q4 - Earnings Call Presentation

March 30th, 2026 4:30 PM Eastern Time Fourth Quarter & Year-end 2025 Operating & Financial Results Conference Call / Webinar NASDAQ :LTRN Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among other things, statements relating to: future events or our future financial performance; the potenti ...